Research & Development
29 September 2023 - Medical device company SeaStar Medical Holding Corporation (Nasdaq:ICU) announced on Friday that it has secured Breakthrough Device Designation from the US Food and Drug Administra...
28 September 2023 - Biopharmaceutical company Akebia Therapeutics Inc (Nasdaq:AKBA) said on Thursday that it has resubmitted its New Drug Application (NDA) for vadadustat to the US Food and Drug Admin...
28 September 2023 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, said on Thursday that it has received priority review status from the US Food and D...
28 September 2023 - Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX), a Sweden-based specialty pharmaceutical company, announced on Wednesday that it has received orphan drug design...
28 September 2023 - Evommune, Inc., a California-based biotechnology company, announced on Wednesday that it has signed a strategic collaboration with Maruho Co., Ltd., a Japan-based pharmaceutical co...